The global advanced wound dressing market size is valued at USD 6.9 billion in 2021 and is predicted to reach USD 11.9 billion by 2030, representing a CAGR of 6.02% over the forecast period (2022–2030). Items for treating acute and chronic wounds, such as lesions, burns, and post-operative injuries, are included in advanced wound care. Advanced wound care treatments such as film and foam dressings, hydrogels, alginates, and hydrocolloids keep the wound moist and accelerate healing without obstructing the process. The advanced wound care industry can help people with chronic wounds by providing them with easily accessible and reasonably priced items that they can use at their leisure. Chronic wounds are becoming more common, surgeries are becoming more common, and technological advancements are driving the market forward.
Get more information on this report Download Sample Report
The global increase in the incidence of chronic diseases such as diabetes, cancer, and other autoimmune diseases. Antimicrobial resistance, the adoption of unhealthy and sedentary lifestyles, alcohol consumption, and smoking are all key contributors to the prevalence of non-communicable illnesses. According to National Diabetes Statistic Report 2017, published by the Centers for Disease Control and Prevention (CDC), more than 100.0 million people in the US were living with diabetes or prediabetes conditions. Furthermore, the World Health Organization estimates that diabetes caused nearly 1.6 million deaths worldwide in 2016.
The number of procedures performed has increased due to the rising frequency of chronic illnesses. As a result, wound care solutions are utilized more frequently to avoid surgical site infections. Most surgical wounds after cancer surgery are large and deep, resulting in exudates that must be handled often—advanced wound dressings including hydrogel, alginate, and foam aid in wound management and infection prevention. As a result, increased chronic illness incidence is predicted to enhance demand for wound care products, pushing market expansion.
The market is expected to develop due to an increase in the number of incidents such as car accidents, burns, and trauma events occurring around the world. According to the WHO (2018), over 1,000,000 individuals are severely or moderately burned in India. Furthermore, according to NCBI, the incidence of burn wounds increased in 2017 in countries such as Bulgaria, Finland, the Netherlands, China, Australia, and the United Kingdom. Furthermore, the American Association for the Surgery of Trauma estimates that 1.2 million people died in automobile accidents worldwide in 2017, with 3,242 people dying per day. Road accidents are more common in countries with moderate or low income. Thus, the rising number of casualties is expected to boost the demand for advanced wound dressing, likely leading to considerable market growth over the forecast period.
The US FDA classifies most wound dressing products under Class I medical devices, exempted from premarket approval. A surgical dressing covers open incision wounds; thus, these products must be free from microbial contamination and manufactured in a sterile environment. Any form of microbial contamination may hinder the wound healing process and, in extreme cases, may cause additional infection at the site. Thus, manufacturing companies may not need premarket approval, but they may be required to comply with the Good Manufacturing Practices (GMP). According to these policies, the wound dressing products must be manufactured under sterile conditions. They have to undergo an extensive quality control process before launching the product.
The growing workforce for home care services can be ascribed to the rapidly increasing demand for home healthcare services. This is projected to be a significant market driver for improved wound dressings. As per the US Bureau of Labor Statistics, the number of home healthcare and personal care aides in the United States will reach 13 million by 2020. Furthermore, as the senior population grows, home healthcare services will likely become more popular, as older individuals are more inclined to use them.
As per the Population Reference Bureau, the proportion of people aged 65 and up in the United States will rise from 52 million in 2018 to 95 million by 2060. According to this, the geriatric population in the United States will grow from 16% of the total population in 2018 to 23% in 2060. Patients who need surgery must stay in hospitals for extended periods; as a result, most patients choose home treatment for hospital stays. Patients benefit from these services, including personal care and home-delivered meals, among other things. Hence, demand for home healthcare services is predicted to increase, leading to market growth over the forecast period.
The COVID-19 pandemic has positively impacted the healthcare industry. Increasing demand for advanced wound dressing is anticipated to drive the market over the forecast period. Face masks are indicated to avoid the spread of the infection, resulting in severe skin damage requiring many wound care treatments to heal. In addition, personal protective equipment, such as masks, gloves, and gowns, cause skin rashes and wounds that require immediate treatment. Otherwise, it might lead to infection. Such parameters are expected to impact the demand for wound care products positively.
Although the outbreak of COVID-19 has disrupted the supply chain across all sectors due to travel restrictions, reduced human resources, and lockdown in various industrial hubs, wound care supplies are critical in this current situation. Disruption in its supply might increase the number of cases and fatalities, product shortages in healthcare facilities, and low profits for healthcare companies. One of the primary restraints that the supply chain vertical of every company faced was a limited movement across borders and national export bans.
As a result of the COVID-19 outbreak, healthcare institutions such as hospitals have been overburdened with corona patients, and several countries have put off elective surgeries and other medical operations indefinitely. Therefore, patients with acute and persistent wounds must be treated at home or in outpatient clinics. As a result, demand for wound care products at home has skyrocketed. Furthermore, the need for home healthcare among the elderly is rising, as they are at a higher risk of infection and cannot visit a healthcare facility. Furthermore, many people have turned to internet counseling for their medical issues.
As the pandemic is growing in many countries and has spread across the globe, the supply chain vertical has been affected the most by the healthcare companies, negatively impacting the wound care market. However, companies adopted many strategies to maintain their product sale to meet the demand. For instance, a small part of Mölnlycke Health Care AB’s supply chain has been affected due to the spread of COVID-19. The company has limited production in China and has many independent production units in various countries. To tackle the supply chain disruption, strategies adopted by the company are rerouting logistics, sourcing from additional partners, and quick delivery with air freight.
Similarly, ConvaTec Group PLC takes every opportunity to reinforce its supply chain. Measures taken by the company are collaborating across the global operation team and liaising with their partners, which include logistics and freight providers. They have also established a group working on these strategies to be implemented in the near future during the pandemic.
Key players in the market are launching products to provide online counseling and guidance to patients who cannot visit healthcare facilities for treatment. For instance, Healogics, Inc. has launched Healogics Telehealth Program, telehealth for wound care patients during the COVID-19 crisis. It provides access to continued wound care to patients and options of wound care treatments to help limit the potential need for hospitalization or emergency room admission. Some wound care centers are adjusting to support hospitals with COVID-19 treatment. Therefore, this program allows patients to receive continuous wound care at these centers.
The global advanced wound dressing market share is segmented by product, application, end-user, and region.
By product, the global advanced wound dressing market is divided into foam, hydrocolloid, film, alginate, hydrogel, collagen, and other advanced dressing. The hydrocolloid dressing segment held a significant share in 2021 and is anticipated to witness the fastest growth rate over the forecast period. It is estimated to reach an expected value of USD 2,080 million by 2030 at a CAGR of 5%. Hydrocolloid dressings are composed of gel-forming agents such as carboxymethylcellulose (CMC) and gelatin. These materials are occlusive, which helps in moisture retention. These dressings promote quick healing and are resistant to bacterial infection. As a result, it aids in wound protection both internally and externally.
Further, growing diabetes cases worldwide are expected to drive category growth over the forecast period. According to the CDC, roughly 5% of adults in the United States were diagnosed with Type 1 diabetes in 2015. Approximately 15% of this diabetic population suffers from diabetic wounds or diabetic ulcers. As a result, demand for hydrocolloid wound dressing is predicted to increase over the forecast period.
By application, the global advanced wound dressing market is divided into chronic and acute wounds. The acute wound segment held the largest market share in 2021. It is estimated to reach an expected value of USD 6,430 million by 2030 at a CAGR of 4.5%. The acute wounds comprise surgical and traumatic wounds and burns. The surgical and traumatic wounds segment held the largest share, owing to the increasing cases of trauma in the US. As per the World Health Organization (WHO), in 2019, around 9% of global mortality occurs due to trauma every year.
By end-user, the global advanced wound dressing market is divided into hospitals, specialty clinics, home healthcare, and others. The hospital segment dominated the market. It is estimated to reach an expected value of USD 4,850 million by 2030 at a CAGR of 4.5%. The rising prevalence of diabetic foot ulcers and venous leg ulcers is the primary segment expansion driver. Furthermore, the increasing likelihood of surgical wounds due to the expanding number of surgeries is propelling the industry forward. SSI wounds are usually treated using advanced wound dressing. As a result, such variables may boost segment growth during the predicted period.
By region, the global advanced wound dressing market is divided into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
Regional Growth Insights Request Sample Pages
North America dominated the advanced wound dressing market in 2021 and is expected to show a considerable growth rate over the forecast period. It is estimated to reach an expected USD 6,835 million by 2030 at a CAGR of 8.5%. Increasing road accidents, sports injuries, and several key players in the region are anticipated to drive the market growth. In addition, the presence of adequate skilled professionals and highly developed healthcare infrastructure is also expected to drive market growth over the forecast period.
In 2021, the United States had the highest share of the North American advanced wound dressing market. Well-developed healthcare infrastructure, increasing awareness about the usage of advanced wound care products, and several key market players are the primary drivers of the market. In addition, an increase in the number of orthopedic procedures due to the high prevalence of sports injuries is also anticipated to drive the market.
Europe advanced wound dressing market is driven by factors such as the presence of well-established healthcare infrastructure and the availability of skilled professionals. It is estimated to reach an expected USD 2,700 million by 2030 at a CAGR of 4%. Moreover, favorable reimbursement coverage has increased the adoption of surgical procedures. In addition, the increasing geriatric population and rising cases of burns and trauma are also anticipated to drive the market. Thus, Europe advanced wound dressing market is expected to witness significant growth over the forecast period.
|Market Size||USD in Billion By 2030|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends|
|Segments Covered||by Product (Foam, Hydrocolloid), Application (Chronic, Acute Wounds), End-User (Hospitals, Specialty Clinics)|
|Geographies Covered||North America, Europe, Asia-Pacific, LAME and Rest of the World|
|Key Companies Profiled/Vendors||Smith & Nephew PLC, Mölnlycke Health Care AB, ConvaTec Group PLC, Johnson & Johnson, Baxter, Coloplast Corp., Medtronic, 3M, Medline Industries, Inc., Integra LifeSciences,|
|Key Market Opportunities||The Medical Devices Industry'S Substantial Growth Fuels The Advanced Wound Dressing Market|